Product Details
Cryopreservation is a vital component of any Assisted Reproductive Technology (ART) program. In Europe, 37.8% of all embryo transfers involve embryos that have been cryopreserved and subsequently thawed. Vitrification, a flash-freezing process, significantly enhances embryo survival rates post-thaw compared to traditional slow-freezing methods. This technique minimizes the risk of ice formation, ensuring better outcomes for embryo preservation.
However, the current vitrification process is complex and manual, presenting several challenges:
Genea Biomedex is committed to simplifying and enhancing this process, ensuring consistent, high-quality results in ART programs.
However, the current vitrification process is complex and manual, presenting several challenges:
- Equilibration Variables: Success relies heavily on precise control over the volume and timing of embryos' exposure to cryoprotectant solutions.
- Manual Handling: Embryologists must manually transfer embryos between solutions, which can introduce stress and potential damage to the embryos.
- Inconsistent Results: Due to its labour-intensive nature, outcomes can vary between different clinics and practitioners.
- Highly Skilled Practitioners Required: The process demands extensive training and experience to manage the numerous critical variables effectively.
- Manual Handling: Embryologists must manually transfer embryos between solutions, which can introduce stress and potential damage to the embryos.
Genea Biomedex is committed to simplifying and enhancing this process, ensuring consistent, high-quality results in ART programs.